Nortech Systems Inc. 10-Q Summary
Business Context and Reporting Period
Company: Nortech Systems Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010
Business Overview: A full-service Electronics Manufacturing Services (EMS) contract manufacturer specializing in wire and cable assemblies, printed circuit board assemblies, and box builds. Primary markets include Aerospace and Defense, Medical, and Industrial Equipment. The company operates facilities in Minnesota, Wisconsin, and Mexico.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $21,741,441 | $21,550,636 |
| Gross Profit | $2,639,668 | $830,564 |
| Gross Margin | 12.1% | 3.9% |
| Operating Income | $325,782 | ($2,123,040) |
| Net Income | $95,284 | ($1,289,218) |
| Diluted EPS | $0.03 | ($0.47) |
| Cash from Operations | $589,671 | ($3,083,293) |
| Cash & Equivalents (End) | $0 | $41,487 |
| Working Capital | $13,494,508 | N/A |
| Current Ratio | 1.68 | N/A |
Debt & Liquidity: As of March 31, 2010, the company had a Line of Credit balance of $5,015,607 with $4.3 million in unused availability. Total current liabilities were $19.7 million. The company reported zero cash and cash equivalents at period end, a decrease of $245,381 from the beginning of the quarter.
Material Changes vs. Prior Period
- Profitability Turnaround: The company returned to profitability, reporting a net income of $95,284 compared to a net loss of $1.3 million in Q1 2009. Operating income improved from a loss of $2.1 million to a profit of $325,782.
- Gross Margin Expansion: Gross margin increased significantly to 12.1% from 3.9% year-over-year, driven by cost reduction initiatives and capacity restructuring implemented in late 2009.
- Revenue Mix Shift: While total sales remained flat (+1%), the composition changed. Aerospace and Defense sales declined 48% due to contract endings, while Medical (+36%) and Industrial (+34%) sectors saw significant growth.
- Backlog Growth: The 90-day order backlog increased 25% year-over-year to $19.0 million, indicating improved customer confidence.
- Inventory Build: Inventories increased by $1.7 million to $17.5 million to support increased customer orders, partially offset by a $1.5 million increase in accounts payable.
Guidance, Outlook, and Risks
Management Commentary: Management attributes the return to profitability to cost controls, continuous improvement programs, and the realization of benefits from the 2009 restructuring. The company expects the annual effective tax rate for 2010 to be approximately 36%.
Subsequent Event: On May 4, 2010, the company acquired the intellectual property and assets of Trivirix Corporation for approximately $403,000 to expand capabilities in medical electronics.
Risks and Contingencies:
- Customer Concentration: GE's Medical and Transportation Divisions combined accounted for 29% of net sales in Q1 2010. Northrop Grumman accounted for 2%.
- Liquidity: Cash balances were depleted to zero during the quarter. The company relies on its line of credit and operating cash flows to meet working capital needs.
- Market Volatility: Risks include volatility in raw material costs (e.g., copper), commodity instability, and general economic conditions affecting demand.
- Restructuring: While major restructuring charges occurred in 2009, the company noted potential for additional impairment or restructuring charges in the future.
Investor Verification Checklist
- Cash Position: Verify the sustainability of operations with $0 cash on hand and reliance on the $4.3 million remaining line of credit availability.
- Customer Concentration: Assess the risk associated with GE representing nearly 30% of sales and the impact of the 48% decline in Aerospace/Defense revenue.
- Inventory Levels: Monitor the $1.7 million inventory increase to ensure it converts to sales without requiring significant write-downs.
- Debt Covenants: Confirm continued compliance with Wells Fargo Bank covenants regarding financial performance and capital expenditures.
- Acquisition Integration: Evaluate the strategic fit and financial impact of the subsequent Trivirix Corporation acquisition.